1.        Liu, Hong; Chen, Haolin; Liu, Zhijia; Le, Zhicheng; Nie, Tianqi; Qiao, Dongdong; Su, Yan; Mai, Haiqiang; Chen, Yongming; Liu, Lixin. Therapeutic nanovaccines sensitize EBV-associated tumors to checkpoint blockade therapy. Biomaterials, 2020, 255: 120158. (中科院&JCR一区，IF=15.304).

2.        Liu, Hong; Hu, Zhitao; Chen, Haolin; Yan, Yanzi; Le, Zhicheng; Wei, Cong; Cao, Wenqiang; Chen, Tianfeng; Chen, Yongming; Liu, Lixin. Self-degradable poly(β-amino ester)s promote endosomal escape of antigen and agonist. Journal of Controlled Release, 2022, 345: 91-100. (中科院&JCR一区，IF=11.467).

3.        Liu, Hong; Wen, Zhenfu; Chen, Haolin; Yang, Zeyu; Le, Zhicheng; Liu, Zhijia; Chen, Yongming; Liu, Lixin. Nanoadjuvants Actively targeting lymph node conduits and blocking tumor invasion in lymphatic vessels. Journal of Controlled Release. 2022, 352: 497-506. ( 中科院&JCR一区，IF=11.467).

4.        Chen, Haolin; Li, Yuhui; Li, Liyan; Yang, Zeyu; Wen, Zhenfu; Cao, Wenqiang; Liu, Lixin*; Liu, Hong*; Chen, Yongming*. Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infections. Acta Biomaterialia, 2023, 158, 525-534. (中科院&JCR一区，通讯，IF=10.633).

5.        Xu, Jiabin; Liu, Hong*; Wang, Tao; Wen, Zhenfu; Chen, Haolin; Yang, Zeyu; Li, Liyan; Yu, Shan; Gao, Siyong; Yang, Le; Li, Kan; Li, Jingyuan; Li, Xiang; Liu, Lixin; Liao, Guiqing*; Chen, Yongming*; Liang, Yujie*. CCR7 mediated mimetic dendritic cell vaccine homing in lymph node for head and neck squamous cell arcinoma herapy. Advanced Science, 2023, 2207017 (中科院&JCR一区，通讯&共一，IF=17.521).

6.        Liu, Hong; Tan, Yan; Xie, Lisi; Yang, Lei; Zhao, Jing; Bai, Jingxuan; Huang, Ping; Zhan, Wugen; Wan, Qian; Zou, Chao. Self-assembled dual-modality contrast agents for non-invasive stem cell tracking via near-infrared fluorescence and magnetic resonance imaging. Journal of Colloid and Interface Science, 2016, 478: 217–226. (JCR一区，IF=9.965).

7.        Zhao, Qianqian; Xin, Liang; Liu, Yuzhi; Liang, Chengyuan*; Li, Jingyi; Jian, Yanlin; Li, Han; Shi, Zhenfeng*; Liu, Hong*; Cao, Wenqiang. Current landscape and future perspective of oxazolidinone scaffolds containing antibacterial drugs. Journal of Medicinal Chemistry, 2021, 64: 10557-10580. (JCR一区，通讯，IF=8.039).

8.        Xu, Jiabin; Cao, Wenqiang; Wang, Penglai; Liu, Hong*. Tumor-derived membrane vesicles: a promising tool for personalized immunotherapy. Pharmaceuticals, 2022, 15(7). (JCR一区，通讯，IF=5.215).

9.        Tian, Lei; Qiang, Taotao; Liang, Chengyuan *; Ren, Xiaodong *; Jia, Minyi; Zhang, Jiayun; Li, Jingyi; Wan, Minge; Yuwen, Xin; Li,Han; Cao, Wenqiang*, Liu, Hong*. RNA-dependent RNA polymerase (RdRp) inhibitors: the current landscape and repurposing for the COVID-19 pandemic. European Journal of Medicinal Chemistry, 2021, 213: 113201. (JCR一区，通讯，IF=7.088).

10.    Liang, Chengyuan*; Qiao, Guaiping; Liu, Yuzhi; Tian, Lei; Hui, Nan; Li, Juan; Ma, Yuling; Li, Han; Zhao, Qianqian; Cao, Wenqiang; Liu, Hong*; Ren Xiaodong. Overview of all-trans-retinoic acid (ATRA) and its analogues: Structures, activities, and mechanisms in acute promyelocytic leukaemia. European Journal of Medicinal Chemistry, 2020, 220: 113451. (JCR一区，通讯，IF=7.088).

11.    Liu, Yuzhi; Liang, Chengyuan*; Xin, Liang; Ren, Xiaodong; Tian, Lei; Ju, Xingke; Li,Han; Wang, Yongbo; Zhao, Qianqian; Liu, Hong*; Cao, Wenqiang; Xie, Xiaolin; Zhang, Dezhu; Wand, Yu; Jian, Yanlin*. The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020. European Journal of Medicinal Chemistry, 2020, 206: 112711. (JCR一区，通讯，IF=7.088).